1. The Role of α-Enolase on the Production of Interleukin (IL)-32 in Con A-Mediated Inflammation and Rheumatoid Arthritis (RA)
   Hyejung Jo et al, 2024, Pharmaceuticals CrossRef
2. Role of interleukin‑32 in cancer progression (Review)
   Danyang Meng et al, 2023, Oncology Letters CrossRef
3. Predictive Value of MUC5AC Signature in Pancreatic Ductal Adenocarcinoma: A Hypothesis Based on Preclinical Evidence
   Ashish Manne et al, 2023, International Journal of Molecular Sciences CrossRef
4. Application of Proteomics in Pancreatic Ductal Adenocarcinoma Biomarker Investigations: A Review
   Christina Jane Vellan et al, 2022, International Journal of Molecular Sciences CrossRef
5. Interleukin‑32 regulates downstream molecules and promotes the invasion of pancreatic cancer cells
   Kohji Takagi et al, 2021, Oncology Letters CrossRef
6. IL-32 and its paradoxical role in neoplasia
   Jacob T. Hough et al, 2023, Critical Reviews in Oncology/Hematology CrossRef
7. SPARC accelerates biliary tract cancer progression through CTGF-mediated tumor–stroma interactions: SPARC as a prognostic marker of survival after neoadjuvant therapy
   Hirotoshi Takayama et al, 2023, Journal of Cancer Research and Clinical Oncology CrossRef
8. A Paradoxical Effect of Interleukin-32 Isoforms on Cancer
   Saerok Shim et al, 2022, Frontiers in Immunology CrossRef
9. Oxidative Stress Markers Are Associated with a Poor Prognosis in Patients with Pancreatic Cancer
   Miguel A. Ortega et al, 2022, Antioxidants CrossRef